NIKKEI 225
27,667.71 +200.48 (+0.73%) HANG SENG
24,683.42 +555.57 (+2.30%) CRUDE OIL
87.06 +0.10 (+0.11%) GOLD FUTURES
1,840.00 -3.20 (-0.17%) DOW
35,028.65 -339.82 (-0.96%) BTC-GBP
30,780.14 -29.74 (-0.10%)
Novavax, Inc. (NVAX)
After hours:
| Previous close | 98.44 |
| Open | 100.15 |
| Bid | 90.75 x 1000 |
| Ask | 93.75 x 1200 |
| Day's range | 91.70 - 103.57 |
| 52-week range | 91.70 - 331.68 |
| Volume | |
| Avg. volume | 5,916,755 |
| Market cap | 6.981B |
| Beta (5Y monthly) | 1.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -14.95 |
| Earnings date | 28 Feb 2022 - 04 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 270.00 |
- Editor's pickYahoo Finance Video
COVID-19: 'Vaccination is the way' to keep the economy open, doctor says
Dr. Taison Bell, Assistant Professor of Medicine at the University of Virginia, joins Yahoo Finance Live to discuss Virginia getting rid of its mask mandate for schools, the Omicron variant, and coronavirus vaccinations.
- Motley Fool
Could Novavax Go Parabolic?
Novavax has resolved manufacturing issues and gained authorization in more than 30 countries. Novavax may be on its way to generating billions of dollars in revenue. With all of this good news, could Novavax stock go parabolic?
- Yahoo Finance Video
Omicron: Why a fourth dose of coronavirus vaccines may not be 'absolutely necessary,' doctor says
Dr. Robert G. Lahita MD, PhD, Director of the Institute for Autoimmune and Rheumatic Disease at Saint Joseph Health and author of Immunity Strong, joins Yahoo Finance Live to discuss the latest information on COVID-19 booster vaccinations, transmissibility, and the pressures felt by hospitals in remote regions.
